Guardant Health vs Natera
GH and NTRA side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GH and NTRA compare
Natera is the larger company, worth 2.5 times as much as Guardant Health ($59.7B against $24.0B).
Guardant Health grew revenue faster over the last twelve months (42.7% versus 37.8% for Natera).
Natera keeps more of each dollar of sales as profit, with a net margin of −7.1% compared with −38.3% at Guardant Health.
Natera scores higher on the StockData Score (10 against 9 for Guardant Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GH | NTRA |
|---|---|---|
| Size and price | ||
| Market cap | $24.0B | $59.7B |
| Share price | $178.80 | $414.30 |
| Change, 1 year | 147% | 115% |
| Change, 5 years | 62.3% | 257% |
| Beta (5Y) | 1.61 | 1.34 |
| Employees | 2,506 | 6,140 |
| StockData Score | ||
| Total score | 9 | 10 (better) |
| Valuation score | 0 | 0 |
| Growth score | 3 | 3 |
| Performance score | 1 | 2 (better) |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 20.3× (better) | 22.1× |
| P/B | – | 32.8× |
| P/FCF | – | 709× |
| FCF yield | −1.0% | 0.14% (better) |
| Fair value | – | $124.09 |
| Margin of safety | – | −234% |
| Growth | ||
| Revenue growth (TTM) | 42.7% (better) | 37.8% |
| Revenue growth, 5Y average | 27.9% | 42.6% (better) |
| Profitability | ||
| Gross margin | 65.0% | – |
| Operating margin | −39.7% | −10.7% (better) |
| Net margin | −38.3% | −7.1% (better) |
| FCF margin | −20.3% | 3.1% (better) |
| Return on equity | – | −12.5% |
| Return on invested capital | – | −40.8% |
| Financial health | ||
| Debt / equity | – | 0.04 |
| Interest coverage | −97.6× | −75.9× (better) |
| Current ratio | 4.03 (better) | 3.00 |
| Altman Z-score | 4.83 | 42.48 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Buyback yield | 0.00% | – |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 99.8% | 95.2% |
| Held by insiders | 1.9% | 4.0% |
| Insider net buying, 12 months | −$174M (better) | −$371M |
| Superinvestors holding | – | 3 |
| Short interest, % of float | 9.1% | 4.6% |
Go deeper
- GH stock overview
- GH income statement
- GH valuation and score
- NTRA stock overview
- NTRA income statement
- NTRA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.